TABLE 2.
Treatment effects of simvastatin 80 mg in FH patients
| Baseline n = 514 | After Two Years n = 436 | % Change | Pa | |
| TC (mmol/L) | 10.52 ± 2.17 | 6.30 ± 1.41 | −39.2 ± 11.8 | <0.0001 |
| LDL cholesterol (mmol/L) | 8.38 ± 2.14 | 4.29 ± 1.31 | −48.0 ± 13.5 | <0.0001 |
| HDL cholesterol (mmol/L) | 1.23 ± 0.35 | 1.36 ± 0.36 | 12.7 ± 21.8 | <0.0001 |
| Triglycerides (mmol/L) | 1.80 (1.20 to 2.40) | 1.20 (0.90 to 1.70) | −26.3 (−46.2 to −5.6) | <0.0001 |
| Total bilirubin (μmol/L) | 10.0 (7.8 to 12.8) | 10.8 (7.8 to 13.7) | 7.0 (−14.1 to 31.1) | <0.0001 |
| ASAT (U/l) | 20 (17 to 24) | 23 (19 to 27) | 14 (0 to 32) | <0.0001 |
All values are given as median with IQR between brackets; only TC, LDL-C, and HDL-C levels are given as mean levels ± SD.
Baseline versus after two years.